Yes, increase the prazosin dose - 6 mg is below the therapeutic range typically needed for nightmare control in PTSD.
You should titrate the prazosin dose upward, as the current 6 mg dose is suboptimal and well below the effective doses demonstrated in clinical trials.
Dosing Evidence and Rationale
The evidence strongly supports higher dosing than your patient's current regimen:
In the 2013 active-duty military trial, mean effective bedtime doses were 15.6 mg for men and 7.0 mg for women, with significant improvement in nightmares compared to placebo 11
In veteran populations, effective doses commonly ranged from 13 mg (mean dose in one RCT) to as high as 20 mg, with therapeutic dosages most commonly between 6-15 mg daily 12
The FDA labeling indicates therapeutic doses for hypertension range from 6-15 mg daily in divided doses, with some patients benefiting from up to 40 mg daily 2
Case reports document safe use of prazosin up to 30-45 mg daily for PTSD with good tolerability 3
Practical Titration Approach
Increase gradually to minimize orthostatic hypotension:
- Increase by 1-2 mg every 3-7 days as tolerated
- Target dose: 10-16 mg at bedtime for most patients
- Monitor blood pressure, especially after dose increases
- Check for dizziness, lightheadedness, or syncope
The patient is currently at the lower end of the therapeutic range - most studies showing efficacy used mean doses of 9-16 mg 114.
Important Caveats
Check for medication interactions that may reduce efficacy:
- Concurrent SSRI/antidepressant use significantly reduces prazosin response - the 2013 military trial showed markedly decreased efficacy in patients on SSRIs (CAPS decrease of 9.6 vs 30.1 in those not on SSRIs) 11
- If your patient is on an antidepressant, this may explain partial response and you may need even higher prazosin doses
- Interestingly, benzodiazepine co-administration may enhance prazosin efficacy for insomnia and PTSD severity 5
Evidence Quality Note
While a large 2018 VA study (304 patients, mean dose 14.8 mg) showed no benefit over placebo, the American Academy of Sleep Medicine guideline acknowledges this contradictory finding but notes that "many patients respond very well to prazosin and this agent remains the first choice for pharmacologic therapy" 11. The negative trial had 78% of patients on concurrent antidepressants, which may explain the null result.
Bottom line: Your patient at 6 mg is undertreated. Titrate upward to at least 10-15 mg at bedtime, monitoring for hypotension, and reassess response at that therapeutic dose before considering prazosin a failure.